Real estate developers continue to report healthy booking momentum, particularly in the mid-income and premium housing segments. New project launches across key urban markets have picked up pace as developers capitalise on sustained end-user demand.
Real estate developers continue to report healthy booking momentum, particularly in the mid-income and premium housing segments. New project launches across key urban markets have picked up pace as developers capitalise on sustained end-user demand.
Brokerages are urging investors to remain cautious on richly valued IPOs, particularly in emerging sectors. While growth narratives remain attractive, earnings sustainability is under sharper scrutiny.
Retail investors are turning increasingly selective while evaluating new public offerings. Recent IPO data indicates that participation levels vary sharply depending on valuation comfort and business visibility.
Bitter but Real Truth of Indian Markets Despite the Budget and US trade deal events concluding, markets show no enthusiasm as 80–90% stocks remain 30–90% below their highs and every minor rise attracts selling due to lack of fresh inflows. As per market grapevine, frustrated investors are gradually shifting funds from equities and mutual funds toward PPF, bank FDs, debt funds, gold, silver and ETFs.
Fractal Industries has opened its SME IPO for subscription between 16th February and 18th February 2026. The public issue aims to raise about Rs. 49 cr through a fresh issue.
The Securities and Exchange Board of India has granted approval to five companies — including Duroflex and Premier Industrial Corporation — to proceed with their public issues.
Shares of PAN HR Solutions entered the BSE SME platform with a muted debut, listing near its issue price of Rs. 78. The stock opened at Rs. 78.35, broadly in line with grey market expectations.
India’s AI-focused firm Fractal Analytics witnessed strong investor traction as its Rs. 2,834 cr IPO achieved full subscription on the last day of bidding. Institutional investors led the demand, while retail participation remained relatively moderate.
Invicta Diagnostic began commercial operations at its Dadar centre from 30th January 2026, offering advanced and routine diagnostics including PET-CT, CT, Sonography, Pathology and X-Ray with proximity to Tata Memorial Hospital expected to support oncology-led volumes.
Caution: For private circulation only. Please note that Money Times Weekly is for circulation among paid subscribers only. Any attempt to share your access to our website or forwarding your copy to a non-subscriber will disqualify your membership and we will be compelled to stop your supply and forfeit your subscription thereafter without any refund […]
For those of you who are serious about having more, doing more, giving more and being more, success is achievable with some understanding of what to do.
